| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919674 | Radiotherapy and Oncology | 2011 | 8 Pages |
Abstract
The benefit of the addition of chemotherapy to locoregional treatment is consistent in all tumour locations of HNSCC. The higher benefit of concomitant schedule was demonstrated only for oropharyngeal and laryngeal tumours but this may be only a consequence of a lack of power.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Pierre Blanchard, Bertrand Baujat, Victoria Holostenco, Abderrahmane Bourredjem, Charlotte Baey, Jean Bourhis, Jean-Pierre Pignon, on behalf of the MACH-CH Collaborative group on behalf of the MACH-CH Collaborative group,